2m 2m 2m 2m 2m 2m 2m
NEURAXIS (NRXS)
NYSE
$7.12+$0.12 (+1.64%)
Price as of Jun 23, 2026 7:44 PM EDT- $88.7MMarket Cap
- 186.89%1-Year Change
- BiotechnologyIndustry
NEURAXIS (NRXS)
$7.12+$0.12 (+1.64%)
NRXS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.00 | ||
Change | -$0.16 (-2.23%) | ||
Open | $7.00 | ||
High | $7.30 | ||
Low | $7.00 | ||
Previous Close | $7.16 | ||
Volume | 65,996 | ||
30-Day Average Volume | 123,877 | ||
1-Week Change | 4.32% | ||
1-Month Change | -5.15% | ||
1-Year Change | 186.89% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.4M | ||
Total Assets | $8.7M | ||
Market Cap | $88.7M | ||
Enterprise Value | $81.9M | ||
Period: QTR TTM FY | |||
Revenue | $1.6M | ||
Net Income | -$2.0M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$1.9M | ||
EBITDA | -$1.9M | ||
Net Working Capital | $5.3M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 15 | ||
P/E | -40 | ||
PEG | -29 | ||
Price/Free Cash Flow | -72 | ||
Price/Operating Cash Flow | -72 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue